List of works - Stefan Leucht

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

scientific article

What does the PANSS mean?

scientific article published on 27 June 2005

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

scientific article

Clinical implications of Brief Psychiatric Rating Scale scores

scientific article

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

scientific article published on August 7, 2010

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

scientific article (publication date: March 2004)

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

scientific article

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

scientific article

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

scientific article

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

scientific article published on January 22, 2011

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

scientific article

Acamprosate for alcohol dependence

scientific article

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

scientific article

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

scientific article published in February 2002

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

scientific article published in June 2005

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials

scientific article

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons

scientific article

Clozapine versus other atypical antipsychotics for schizophrenia

scientific article (publication date: 2010)

Do patients with schizophrenia wish to be involved in decisions about their medical treatment?

scientific article published on December 2005

Linking the PANSS, BPRS, and CGI: clinical implications

scientific article published on 05 July 2006

Olanzapine versus other atypical antipsychotics for schizophrenia

scientific article (publication date: 2010)

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

scientific article

Maintenance treatment with antipsychotic drugs for schizophrenia

scientific article

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

scientific article published on 8 December 2004

Attitudes of psychiatrists toward antipsychotic depot medication

scientific article published on 01 December 2006

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

scientific article

Risperidone versus other atypical antipsychotics for schizophrenia

scientific article (publication date: 2011)

Shared decision making and long-term outcome in schizophrenia treatment

scientific article published on 01 July 2007

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review

scientific article

Benzodiazepines for schizophrenia

scientific article

Early prediction of antipsychotic nonresponse among patients with schizophrenia

scientific article published on 01 March 2007

The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects

scientific article

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis

scientific article

Lithium for schizophrenia

scientific article

“How to Speak to Your Psychiatrist”: Shared Decision-Making Training for Inpatients With Schizophrenia

scientific article published on October 1, 2011

How to Obtain NNT from Cohen's d: Comparison of Two Methods

scientific article (publication date: 27 April 2011)

Evidence-based pharmacotherapy of schizophrenia

scientific article published on 6 January 2011

Valproate for schizophrenia

scientific article

Aripiprazole versus other atypical antipsychotics for schizophrenia

scientific article (published 2014-01-02)

Haloperidol versus chlorpromazine for schizophrenia

scientific article

Second-generation antipsychotics for major depressive disorder and dysthymia

scientific article published on December 8, 2010

Ziprasidone versus other atypical antipsychotics for schizophrenia

scientific article

Quetiapine versus other atypical antipsychotics for schizophrenia

scientific article

Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials

scientific article

Quetiapine versus other atypical antipsychotics for schizophrenia

scientific article (publication date: 18 November 2013)

Antidepressants for the negative symptoms of schizophrenia

scientific article

Aripiprazole versus other atypical antipsychotics for schizophrenia

scientific article

Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials

scientific article published in September 2004

Amisulpride is an "atypical" antipsychotic associated with low weight gain

scientific article

Second-generation antipsychotics for anxiety disorders

scientific article published on December 8, 2010

List of works by Stefan Leucht

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

What does the PANSS mean?

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Clinical implications of Brief Psychiatric Rating Scale scores

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

Acamprosate for alcohol dependence

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials

Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons

Clozapine versus other atypical antipsychotics for schizophrenia

Do patients with schizophrenia wish to be involved in decisions about their medical treatment?

Linking the PANSS, BPRS, and CGI: clinical implications

Olanzapine versus other atypical antipsychotics for schizophrenia

Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.

Maintenance treatment with antipsychotic drugs for schizophrenia

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

Attitudes of psychiatrists toward antipsychotic depot medication

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

Risperidone versus other atypical antipsychotics for schizophrenia

Shared decision making and long-term outcome in schizophrenia treatment

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review

Benzodiazepines for schizophrenia

Early prediction of antipsychotic nonresponse among patients with schizophrenia

The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis

Lithium for schizophrenia

“How to Speak to Your Psychiatrist”: Shared Decision-Making Training for Inpatients With Schizophrenia

How to Obtain NNT from Cohen's d: Comparison of Two Methods

Evidence-based pharmacotherapy of schizophrenia

Valproate for schizophrenia

Aripiprazole versus other atypical antipsychotics for schizophrenia

Haloperidol versus chlorpromazine for schizophrenia

Second-generation antipsychotics for major depressive disorder and dysthymia

Ziprasidone versus other atypical antipsychotics for schizophrenia

Quetiapine versus other atypical antipsychotics for schizophrenia

Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials

Quetiapine versus other atypical antipsychotics for schizophrenia

Antidepressants for the negative symptoms of schizophrenia

Aripiprazole versus other atypical antipsychotics for schizophrenia

Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials

Amisulpride is an "atypical" antipsychotic associated with low weight gain

Second-generation antipsychotics for anxiety disorders